The digital health revolution is accelerating at an unprecedented pace, transforming how we diagnose diseases, deliver care, and manage wellness. From AI-powere ...

WordPress powers about 43% of all websites worldwide. This makes it an indispensable platform for organizations of all sizes. Unfortunately, that popularity also makes WordPress a prime target for ...

Antibiotic resistance is turning routine infections into life threatening events, and the traditional pipeline for new drugs ...

Have you ever watched your team “save time” with a free AI deck tool… and somehow the week still ends with everyone stressed, ...

A drug maker is looking for participants for a clinical trial involving an investigational Alzheimer's drug, and Baltimore is one of the trial locations.The purpose of Merck's study is to see if the ...

Thousands of bottles of a commonly used prescription drug to treat hypertension has been recalled for possible contamination with another drug. The global drug maker, which is headquartered in Mumbai, ...

Pfizer Inc. pulled off a comeback win, beating out Danish drug giant Novo Nordisk to acquire obesity drug developer Metsera Inc. in a deal that values the biotechnology company at up to $9.1 billion.

Novo Nordisk NOVO.B9.24%increase; green up pointing triangle filed for U.S. Food and Drug Administration approval of CagriSema, a once-weekly shot that combines two compounds to treat obesity.

A New Jersey drug maker is voluntarily recalling thousands of bottles of a prescription drug used to treat hypertension after discovering it could be cross-contaminated with another drug, The Hill ...

If your AI investment needs constant justification, it’s already in trouble. One-time productivity bumps don’t move margins. Demos don’t survive budget reviews. And “AI adoption”...Read More The post ...

DEC 15 (Reuters) - A federal judicial panel said Monday it would centralize a growing number of lawsuits against Novo Nordisk and Eli Lilly alleging patients lost some or all of their eyesight while ...